RecruitingEarly Phase 1NCT06612411
B.Subtilis Attenuate Symptoms in Diarrhea-predominant Irritable Bowel Syndrome by Increasing Hypoxanthine Biosynthesis
Studying Disorder of purine metabolism
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Jinling Hospital, China
- Intervention
- B. subtilis(drug)
- Enrollment
- 180 enrolled
- Eligibility
- 16-80 years · All sexes
- Timeline
- 2024 – 2024
Study locations (1)
- Jinling Hospital, Nanjing, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06612411 on ClinicalTrials.gov